# Phase 3 Study of Plozasiran in Adults With Hypertriglyceridemia

> **NCT06347133** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Arrowhead Pharmaceuticals** · enrollment: 1456 (actual)

## Conditions studied

- Hypertriglyceridemia

## Interventions

- **DRUG:** Plozasiran Injection
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06347133
- **Lead sponsor:** Arrowhead Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-05-21
- **Primary completion:** 2026-05
- **Final completion:** 2026-09
- **Target enrollment:** 1456 (ACTUAL)
- **Last updated:** 2025-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06347133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06347133, "Phase 3 Study of Plozasiran in Adults With Hypertriglyceridemia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06347133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*